Candide B cream 1% 15 g

Release form, composition and packaging

Cream for external use, white, homogeneous.

1 g

beclomethasone (as dipropionate) 250 mcg

clotrimazole 10 mg

benzyl alcohol, white petrolatum, liquid paraffin, cetomacrogol, propylene glycol, methyl parahydroxybenzoate, propyl parahydroxybenzoate, butylhydroxytoluene, sodium phosphate anhydrous, sodium dihydrogen phosphate, purified water.

15 g - aluminum tubes (1) - cardboard packs.

pharmachologic effect

Combined preparation for external use.

Clotrimazole is an imidazole derivative.

Violates the synthesis of ergosterol, which is part of the cell membrane of fungi, which causes a change in its properties and leads to cell lysis.

Beclomethasone is a glucocorticoid that has anti-inflammatory, anti-allergic, anti-exudative, antipruritic effects.

The drug is active against dermatophytes (Trichophyton, Epidermophyton, Microsporum), yeast and yeast-like fungi (Candida, Torulopsis, Rhodoturola), molds, as well as Malassezia furfur, Aspergillus

some strains of gram-positive bacteria (Streptococcus spp., Staphylococcus spp., Corynebacterium minutissimum), gram-negative bacteria (Bacteroides spp., Gardnerella vaginalis), as well as Trichomonas vaginalis.

Pharmacokinetics

Data on the pharmacokinetics of Candide B are not provided.

Indications for use

Skin mycoses (including those complicated by acute eczematous symptoms):

- dermatomycosis of various parts of the body

- athlete's foot

- dermatoses complicated by secondary infection.

Contraindications for use

- specific skin lesions (including tuberculosis, chickenpox, herpes simplex, measles, syphilis)

- skin reactions at the vaccination site

- hypersensitivity to drug components.

Dosage regimen

Before applying the cream, wash and dry the affected area.

The cream should be applied directly to the affected areas, ensuring direct contact of the drug with the skin, incl.

on the hairy areas of the body.

The drug is used 2-3 times / day.

After the disappearance of eczematous symptoms, it is recommended to switch to Candide cream treatment until the primary fungal infection disappears completely.

Overdose

Acute overdose with external use of the drug Candide B is unlikely.

Side effect

Local reactions: skin redness, burning and tingling sensation at the site of application of the drug (if irritation develops, the drug must be canceled).

Possibly: allergic reactions.

Drug interactions

Drug interaction of the drug Candide B is not described.

Application during pregnancy and lactation

The safety of using Candide B during pregnancy and lactation has not been established.

Therefore, you should avoid prescribing the drug in large quantities or for a long time during these periods.

special instructions

The drug is intended for use only in dermatological practice.

The use of the drug Candide B as part of the complex therapy of candidiasis of the anogenital region allows you to quickly achieve a significant improvement in the patient's condition.

It should be borne in mind that with external use of glucocorticoids on large areas of the skin or with occlusive dressings, their systemic absorption is possible.

When using occlusive dressings, it is possible to develop a rash, folliculitis, pyoderma.

Name ENG

CANDID B

Clinical and pharmacological group

Antifungal and anti-inflammatory drug for external use

ATX code

Beclomethasone in combination with antibiotics

Dosage

25mcg / 100mg + 1mg / 100mg x 15g

Structure

beclomethasone (in the form of dipropionate), clotrimazole.

Excipients: benzyl alcohol, white petrolatum, liquid paraffin, cetomacrogol, propylene glycol, methyl parahydroxybenzoate, propyl parahydroxybenzoate, butylhydroxytoluene, sodium phosphate anhydrous, sodium dihydrogen phosphate, purified water.

Indications

Fungal infections of the skin, especially accompanied by acute eczematous manifestations:

epidermophytosis groin, athlete's foot

microsporia of smooth skin

candidiasis due to Candida albicans.

Contraindications

Hypersensitivity

lupus

post-vaccination skin reactions

herpes simplex

cutaneous manifestations of syphilis

actinomycosis, blastomycosis, sporotrichosis

trophic ulcers against the background of chronic venous insufficiency

skin tumors

period of breastfeeding.

INN / Active ingredient

clotrimazole, beclomethasone (in the form of dipropionate)

Storage conditions and periods

In a dark place at a temperature not exceeding 25 degrees.

Expiration date: 3 years

Specifications

Category

Antifungal

Scope of the drug

General

Release form

Cream

Manufacturer country

India

Package quantity, pcs

one

Way of introduction

On the skin

Vacation conditions

Without recipe

Brand name

Glenmark Pharma

,

Glenmark

The amount of the dosage form in the primary package

15 g

Primary packaging type

Tuba

Type of consumer packaging

Pack of cardboard

Dosage form

Cream for external use

Item weight, g

15

Expiration date in days

1095

Package weight, g

15

Mode of application

:

Before applying the cream, wash and dry the affected area.

The cream should be applied directly to the affected areas, ensuring direct contact of the drug with the skin, incl.

on the hairy areas of the body.

The drug is used 2-3 times / day.

After the disappearance of eczematous symptoms, it is recommended to switch to Candide cream treatment until the primary fungal infection disappears completely.

Pharmaco-therapeutic group

:

Topical glucocorticosteroid + antifungal

Anatomical and therapeutic characteristics

:

D07BC Active glucocorticosteroids, in combination with antiseptics

Dosage (volume) of the substance in the preparation

:

In 1 g: beclomethasone (in the form of dipropionate) 250 mcg clotrimazole 10 mg

Information on technical characteristics, delivery set, country of manufacture